🇺🇸 Prednisolone 5 mg in United States

21 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. General Physical Health Deterioration — 3 reports (14.29%)
  2. Abdominal Pain — 2 reports (9.52%)
  3. Anaemia — 2 reports (9.52%)
  4. Back Pain — 2 reports (9.52%)
  5. Death — 2 reports (9.52%)
  6. Diarrhoea — 2 reports (9.52%)
  7. Haematoma — 2 reports (9.52%)
  8. Lower Respiratory Tract Infection — 2 reports (9.52%)
  9. Nausea — 2 reports (9.52%)
  10. Oesophageal Rupture — 2 reports (9.52%)

Source database →

Prednisolone 5 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Prednisolone 5 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Prednisolone 5 mg in United States?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.